Yahoo Web Search

Search results

1. • Analyst Report: Teva Pharmaceutical Industries Limited

     Morningstar Research via Yahoo Finance· 20 hours ago

     Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales ...

2. • Teva- Pharmaceutical Industries Ltd. ADR (TEVA) receives a Neutral rating from JP Morgan – Knox...

     Knox Daily· 6 days ago

     In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million ...

3. • Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded by StockNews.com to “Buy”

     ETF DAILY NEWS· 5 days ago

     Several other equities research analysts have also recently commented on TEVA. JPMorgan Chase & Co. raised Teva Pharmaceutical Industries ...

4. • Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus (NYSE:...

     Benzinga· 3 days ago

     Loading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail ...

5. • ...SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. - Alvotech (NASDAQ:ALVO), Teva ...

     Benzinga· 5 days ago

     Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA

6. • 

     Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune

     Law.com· 3 days ago

     Lawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...

7. • Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug...

     WKRN Nashville· 4 days ago

     Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the U.S. Food and Drug Administration ...

8. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 11 hours ago

     NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the (NYSE: SQSP) Squarespace buyout from Permira. If you invested in Squarespace you are encouraged to obtain additional information by visiting

9. • 10 drugs now in shortage

     Becker’s Hospital Review· 4 days ago

     About a month after the number of ongoing drug shortages reached a 23-year record, more than four dozen patient advocacy groups wrote to legislators, urging them to address the shortages. A ...

10. • 

      Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla

      Zacks via Yahoo Finance· 4 days ago

      Exelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic...